| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.02 |